Moderna Says Vaccine Produces Powerful Immune Response in Those 6 Through 11

The results were announced a day before an advisory committee of the Food and Drug Administration is scheduled to review data for the Pfizer-BioNTech vaccine in children 5 through 11. https://www.nytimes.com